Investors - JUNE 22, 2022

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

Taconic Partners announces new life sciences platform

by Released

Taconic Partners has launched Elevate Research Properties, which will be responsible for the acquisition, development, leasing and management of Taconic’s growing life sciences portfolio.

With three projects in active development along with a recently announced future pipeline deal, Elevate will have approximately $2 billion of investment in life sciences real estate totaling 1.4 million square feet. While all four of these projects are located in Manhattan, Elevate plans to invest in core lab markets outside of New York as well.

Matthew Weir will serve as president of the new venture in addition to his current role as executive vice president of Taconic.

On the West Side of Manhattan, Elevate Research Properties has two active lab developments located within half-a-mile of each other. 125 West End Avenue is a 400,000-square-foot, $600 million lab development delivering in the second quarter of 2023, and The Hudson Research Center is a 320,000-square-foot bui

Forgot your username or password?